BamSEC and AlphaSense Join Forces
Learn More

Fate Therapeutics Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: FATE    
Share price (5/22/26): $2.25    
Market cap (5/22/26): $262 million

Plans of Reorganization, Merger, Acquisition or Similar

No filings in this category.